All In Biotech

Free tool

FAERS Monitor: Monoferric

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208171 or its brand name (Monoferric, Ferric Derisomaltose). Reports on generic versions are filed under their own applications.

Reports

1,366

Serious

726

53% of reports

Hospitalization

230

Death reported

51

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea288
  • nausea162
  • flushing157
  • chest discomfort150
  • back pain127
  • infusion related reaction104
  • dizziness100
  • vomiting92
  • pruritus90
  • chest pain87
  • abdominal pain74
  • hypersensitivity69
  • rash67
  • hypertension64
  • hyperhidrosis63

Reports by year received

View as table
YearReports
20161
20206
2021153
2022189
2023269
2024272
2025282
2026194

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,793 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal10424.220.12,293
flushingSignal15723.820.63,420
chest discomfortSignal15022.619.43,083
back painSignal1278.47.1832
dyspnoeaSignal2887.87.11,757
hyperhidrosisSignal637.55.9352
chest painSignal877.25.9465
hypersensitivitySignal695.74.5267
abdominal painSignal744.93.9228
hypertensionSignal644.73.7182
pruritusSignal903.63.0170
nauseaSignal1623.22.7245
dizzinessSignal1003.12.6142
vomitingSignal923.02.5125
rashSignal672.41.953

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.